Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.
PHASE4CompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
November 30, 2002
Study Completion Date
April 30, 2005
Conditions
Heart Failure
Interventions
DRUG
Levosimendan
Trial Locations (1)
413 45
Cardiology Department, Sahlgrenska University Hospital, Gothenburg
All Listed Sponsors
lead
Orion Corporation, Orion Pharma
INDUSTRY
NCT00219388 - Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients. | Biotech Hunter | Biotech Hunter